|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 665.68 USD | +0.42% |
|
+1.80% | -13.71% |
| 11:55am | Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| Market Cap | 67.44B 59B 54.41B 50.34B 95.54B 6,437B 97.14B 652B 255B 3,161B 253B 248B 10,950B | P/E 2026 * |
17.2x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 59.61B 52.14B 48.09B 44.49B 84.45B 5,690B 85.86B 576B 226B 2,794B 224B 219B 9,678B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.24x |
| Free-Float |
72.33% | Yield 2026 * |
0.59% | Yield 2027 * | 0.67% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.43% | ||
| 1 week | +1.80% | ||
| Current month | +6.81% | ||
| 1 month | +8.09% | ||
| 3 months | -13.26% | ||
| 6 months | -16.39% | ||
| Current year | -13.71% |
| 1 week | 637.72 |  | 677.92 |
| 1 month | 594.9 | | 677.92 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-01 | Sell | Director | -200 | 0.0002% | ||
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | +1.80% | +20.53% | -5.31% | 67.44B | |
| +0.52% | -5.52% | +46.80% | +218.71% | 53.98B | |
| -2.79% | +32.50% | +32.50% | +32.50% | 41.77B | |
| +0.99% | +6.05% | -48.96% | -52.97% | 41.15B | |
| -0.43% | -7.62% | +50.09% | -29.10% | 29.58B | |
| +2.72% | -4.91% | +131.31% | -38.38% | 29.28B | |
| +0.81% | +1.14% | +71.99% | +90.97% | 23.43B | |
| +0.17% | +8.48% | +4.86% | +185.45% | 19.11B | |
| +1.14% | -0.17% | +68.83% | +134.48% | 16.82B | |
| +17.24% | +18.93% | +99.65% | +428.80% | 15.36B | |
| Average | +2.08% | +1.68% | +47.76% | +96.52% | 33.79B | |
| Weighted average by Cap. | +1.05% | +1.23% | +38.61% | +68.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.87B 13.89B 12.81B 11.85B 22.49B 1,515B 22.86B 153B 60.12B 744B 59.59B 58.3B 2,577B | 17.55B 15.35B 14.16B 13.1B 24.86B 1,675B 25.28B 170B 66.46B 823B 65.88B 64.45B 2,849B |
| Net income | 4.06B 3.55B 3.28B 3.03B 5.75B 388B 5.85B 39.24B 15.38B 190B 15.25B 14.92B 660B | 5.11B 4.47B 4.12B 3.81B 7.23B 487B 7.35B 49.32B 19.33B 239B 19.17B 18.75B 829B |
| Net Debt | -7.83B -6.85B -6.32B -5.85B -11.1B -748B -11.28B -75.68B -29.67B -367B -29.41B -28.77B -1,272B | -10.5B -9.19B -8.47B -7.84B -14.88B -1,002B -15.13B -101B -39.77B -492B -39.42B -38.57B -1,705B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | US$666.03 | +0.47% | 291,767 |
| 08/07/26 | US$662.88 | -1.97% | 746,834 |
| 07/07/26 | US$676.23 | +4.07% | 918,937 |
| 06/07/26 | US$649.81 | -0.68% | 714,338 |
| 02/07/26 | US$654.27 | +4.73% | 1,071,604 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
